| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANTX | Common Stock | Other | -$398K | -26.5K | -1.2% | $15.00 | 2.18M | Jun 6, 2022 | Direct | F1, F2 |
| transaction | ANTX | Common Stock | Other | $398K | +26.5K | +6.86% | $15.00 | 413K | Jun 6, 2022 | By Adjuvant Global Health Technology Fund DE, L.P. | F1, F3 |
| Id | Content |
|---|---|
| F1 | On June 6, 2022, Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund") transferred to Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE") 26,511 shares of the Issuer's common stock, with a value of $15.00 per share, which is the per share cost of the shares acquired by AGHT Fund. |
| F2 | Shares held directly by AGHT Fund. The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities. |
| F3 | Shares held directly by AGHT Fund DE. The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities. |